RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide

Este producto es parte de AKT2 - RAC-beta serine/threonine-protein kinase 2
Product Graph
195€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269689
tested applications
P-ELISA

Description

RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide is a synthetic peptide. This peptide is used in the production of

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
RAC-Beta Serine/threonine-Protein Kinase (AKT2)
Host
Synthetic
Assay Type
Activity: Not tested.
Sequence Fragment: C-Terminus: C-RYDSLGLLELDQRT
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Size 1
100 µg
Form
Lyophilized
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
208
NCBI Accession
NP_001617.1
Alias
AKT2,PKB beta,Protein kinase Akt ,Protein kinase B beta
Background
Protein AKT2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in deionized water.

Descripción

Related Products

EH15498

Human AKT2 (RAC-beta serine/threonine-protein kinase) ELISA Kit

Ver Producto
FNab00272

AKT2 antibody

AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis and their activation has been observed in a wide variety of cancers. AKT2 is mainly involved in cancer cell survival, apoptosis inhibition, migration and invasion(PMID:21979951). The full length protein has four glycosylation sites.

Ver Producto
P0509

Recombinant Human AKT2

Ver Producto